Top 5 Casino Stocks To Watch Right Now

“Luck is what happens when preparation meets opportunity.” -Seneca

Author’s Note: A more detailed research recommendation report on this sector will appear in our SA Marketplace site The House Edge after oral arguments are heard.

Two weeks from now, the US Supreme Court will hear oral arguments in the landmark case: Christie vs. Professional & Amateur Sports Protection Act (1992) asserting that it, among other injustices, is an undue incursion of the sovereign right of states to legalize wagering on sports. The case springs from a lawsuit by New Jersey Governor Chris Christie. Although online casino play is already legal in that state, sports betting is not. Through a succession of lower court rulings that cited the federal statute, Christie has taken the fight to the nation’s highest court. The outcome of that ruling, to come sometime this year, could trigger a bonanza for companies already in the online wagering sector. The American Gaming Association has issued an amicus curiae brief to the court favoring legal sports betting citing its estimate that it represents $150 in annual revenue to illegal bookmakers, much of which is diverted to finance organized criminal enterprises.

Top 5 Casino Stocks To Watch Right Now: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    AbbVie declared that its Board of Directors has approved a share buyback program on Thursday, December 13th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 3.8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board believes its stock is undervalued.

    TRADEMARK VIOLATION NOTICE: “Diversified Trust Co Buys 253 Shares of AbbVie Inc (ABBV)” was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of international copyright & trademark laws. The legal version of this piece of content can be accessed at www.tickerreport.com/banking-finance/4162805/diversified-trust-co-buys-253-shares-of-abbvie-inc-abbv.html.

    AbbVie Profile

  • [By Keith Speights]

    I think both income-seeking investors and value investors will like AbbVie (NYSE:ABBV) and Gilead Sciences (NASDAQ:GILD). Here’s why these are two cheap dividend stocks that you can buy right now.

  • [By Todd Campbell]

    During hours of discussion, AbbVie (NYSE:ABBV), AstraZeneca (NYSE:AZN), Bristol-Myers Squibb (NYSE:BMY), Johnson & Johnson (NYSE:JNJ), Merck & Co. (NYSE:MRK), Sanofi (NASDAQ:SNY), and Pfizer (NYSE:PFE) answered questions from members of the U.S. Senate Finance Committee. Here are five key takeaways from their appearance on Capitol Hill.

  • [By ]

    2. AbbVie (NYSE: ABBV)
    This favorite stock of Wall Street has been trading above its 50-day simple moving average (SMA) since November 2016. Even the February sell-off did not cause the price to violate support at the 50-day SMA. This tells me one thing: Big money is watching the primary technical indicator and buying every pull back!

Top 5 Casino Stocks To Watch Right Now: CGI Group, Inc.(GIB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CGI Group (GIB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    CGI (TSE:GIB.A) (NYSE:GIB) had its target price raised by stock analysts at Barclays from C$83.00 to C$89.00 in a report issued on Thursday. Barclays’ price objective points to a potential upside of 7.04% from the stock’s previous close.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on CGI (GIB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Shares of CGI (TSE:GIB.A) (NYSE:GIB) have been assigned a consensus recommendation of “Buy” from the ten analysts that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is C$88.70.

Top 5 Casino Stocks To Watch Right Now: China Digital TV Holding Co., Ltd.(STV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Sativacoin (CURRENCY:STV) traded 2.1% higher against the US dollar during the 1-day period ending at 22:00 PM E.T. on May 9th. Over the last week, Sativacoin has traded up 0.1% against the US dollar. One Sativacoin coin can now be purchased for $0.0318 or 0.00000341 BTC on popular exchanges including Cryptopia and YoBit. Sativacoin has a market capitalization of $225,415.00 and $19.00 worth of Sativacoin was traded on exchanges in the last 24 hours.

Top 5 Casino Stocks To Watch Right Now: State Bank Financial Corporation.(STBZ)

Advisors’ Opinion:

  • [By Logan Wallace]

    State Bank Financial (NASDAQ:STBZ) last issued its quarterly earnings results on Thursday, January 25th. The financial services provider reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.03. State Bank Financial had a return on equity of 9.26% and a net margin of 18.77%. The firm had revenue of $68.16 million during the quarter, compared to the consensus estimate of $65.00 million. analysts expect that State Bank Financial will post 2.18 EPS for the current year.

    TRADEMARK VIOLATION WARNING: “Analysts Set State Bank Financial (STBZ) PT at $34.00” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3379591/analysts-set-state-bank-financial-stbz-pt-at-34-00.html.

    State Bank Financial Company Profile

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on State Bank Financial (STBZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Citizens Financial Group (NYSE:CFG) and State Bank Financial (NASDAQ:STBZ) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Top 5 Casino Stocks To Watch Right Now: Health Insurance Innovations, Inc.(HIIQ)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the headlines that may have effected Accern Sentiment’s scoring:

    Get Health Insurance Innovations alerts:

    Health Insurance Innovations (HIIQ) and Brown & Brown (BRO) Critical Survey (americanbankingnews.com) Founder of Tampa health insurance company is out (finance.yahoo.com) Cantor Fitzgerald Reaffirms “Buy” Rating for Health Insurance Innovations (HIIQ) (americanbankingnews.com) Health Insurance Innovations founder out (seekingalpha.com) Health Insurance Innovations (HIIQ) Insider Michael W. Kosloske Sells 1,300,000 Shares (americanbankingnews.com)

    Shares of Health Insurance Innovations opened at $34.35 on Tuesday, according to Marketbeat.com. Health Insurance Innovations has a 1 year low of $12.65 and a 1 year high of $37.38. The stock has a market cap of $559.65 million, a PE ratio of 24.20 and a beta of 0.55.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Health Insurance Innovations (HIIQ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Health Insurance Innovations (NASDAQ: HIIQ) and Crawford & Company (NYSE:CRD.B) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, earnings and profitability.

  • [By Max Byerly]

    Health Insurance Innovations (NASDAQ:HIIQ) insider Michael W. Kosloske sold 1,300,000 shares of the firm’s stock in a transaction on Thursday, June 7th. The shares were sold at an average price of $31.00, for a total value of $40,300,000.00. Following the completion of the sale, the insider now directly owns 100 shares in the company, valued at approximately $3,100. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Health Insurance Innovations (HIIQ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *